YY1 and cervical carcinoma: Specifically, treatment of HeLa cells with arsenic trioxide was shown to reduce YY1 expression, which was correlated with increased apoptosis, suggesting that YY1 could be a potential anticancer target for the treatment of cervical carcinoma [97].